With a client base spanning pharmaceutical, medical devices and biotech companies, Mayer Brown offers a full range of contentious and advisory IP services, covering Hatch-Waxman disputes and infringement allegations, while also overseeing cross-border mergers and joint ventures and associated IP strategies. Leading the team out of New York are Lisa Ferri, who frequently appears before the PTAB and Federal Appeals Courts in complex patent trials, while also working alongside Reb Wheeler to oversee transactions in the sector, including M&A, private equity acquisitions and joint ventures.

Legal 500 Editorial commentary

Key clients

  • Gilead Sciences
  • Roivant Sciences
  • Takeda Pharmaceutical Company Limited
  • Galderma Laboratories, L.P.
  • Sanofi
  • Regeneron
  • GSK
  • Gerber Products Company
  • bioMérieux SA
  • Nestlé Health Science

Lawyers

Leading lawyers
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Lisa Ferri, Reb Wheeler